PATENT CLAIM ANALYSIS

Application Number: 15560145
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "460000"]

Abstract:
The present invention relates to, in part, methods for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS) using at least one anti-methanogenic lovastatin analog or derivative. In addition, modified-release formulations comprising at least one anti-methanogenic lovastatin analog or derivative are provided which release the anti-methanogenic lovastatin analog or derivative in the gastrointestinal tract.

Claim (Index 78):
The method of  claim 74 , wherein the modified-release formulation comprises a modified-release coating having a time-dependent erosion profile.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 91.0
- Lexical Diversity: 1.48889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15940063', '14826115', '15810891', '15656758', '15043223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7284520785571159
- 35 USC 102 Novelty (BERT): 0.5339162595272143
- Combined Prediction Score: 0.7089984966541257
- Mean Citation Score: 239.944296
- Max Citation Score: 335.23923
- Similarity Product: 167.3539567666644

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test